Published company evidence
Read the context behind each recommendation, including the study it came from and the limits of what the evidence can show.
272 published fit reviews
Banner Life is a mixed fit for COPD life insurance. Its OPTerm guide treats COPD as ratable rather than an automatic decline, but COPD is excluded from accelerated underwriting, an Attending Physician Statement is expected, and oxygen use or recent hospitalization may trigger postponement or decline.
Prudential is a mixed-to-good fit for life insurance with COPD, depending on severity. It is strongest for mild-to-moderate, stable COPD, while severe COPD, oxygen use, or recent hospitalization likely triggers a decline or heavy table rating.
Mutual of Omaha is a good fit for COPD applicants needing modest final-expense coverage. Guaranteed-issue whole life is available ages 45-85 with no medical exam, but COPD typically routes applicants to graded benefits with low face amounts and a two-year limited benefit period.
Colonial Penn is a mixed fit for Life Insurance for Kidney Disease. It is a reasonable fallback for applicants roughly ages 50–85 with stage 4–5 CKD or dialysis who cannot qualify for medically underwritten coverage, because its Guaranteed Acceptance Whole Life plan requires no health questions and no medical exam…
Banner Life is a mixed fit for life insurance with kidney disease. OPTerm offers 10-40 year terms and substandard underwriting through Table 12, but Banner Life publishes no kidney-specific grid and excludes chronic kidney disease from accelerated underwriting. Mild, stable Stage 1-2 CKD is the most plausible fit.
John Hancock is a mixed fit for life insurance with kidney disease. Two of seven AI platforms named it, averaging rank 4.0. Its underwriting reviews renal function and Vitality may cut premiums up to 25%, but no public kidney-specific acceptance rule exists and Simple Term with Vitality excludes kidney disease.
Lincoln Financial Group is a mixed fit for life insurance with kidney disease. Two of seven platforms named it during ranking discovery, and it finished seventh overall with an average listed rank of 3.0.
Transamerica is a mixed fit for life insurance with kidney disease. Its Final Expense Solutions Portfolio offers simplified-issue whole life with no medical exam and $1,000-$50,000 of coverage, but public evidence does not establish kidney-disease acceptance criteria or stage-by-stage pricing.
Prudential is a mixed fit for life insurance with kidney disease. Its own underwriting materials allow Preferred Best for stable cases with creatinine at or below 1.5 mg/dL and normal urine, but current dialysis is uninsurable and no public CKD rate table exists.
Gerber life insurance is a mixed but credible fit for life insurance with kidney disease. Five of seven platforms named Gerber Life during the ranking stage, and its relevant product — Gerber Life Guaranteed Life, a guaranteed-issue whole life policy — was evaluated by all seven.
Corebridge Financial is a mixed-to-good fit for life insurance with kidney disease. Select-a-Term may suit earlier-stage CKD, while Guaranteed Issue Whole Life is a fallback for advanced disease. No CKD-specific underwriting rules or premiums are published, so eligibility and pricing stay quote-dependent.
Protective is a mixed fit for life insurance with kidney disease. It is strongest for stable Stage 1-3a CKD seeking fully underwritten term coverage, but kidney disease disqualifies applicants from accelerated underwriting and dialysis is uninsurable.
